Bonnie E. Orlowski

Senior Vice President & Head of Consultant Relations & Financial Intermediaries at Ariel Investments LLC

Bonnie E. Orlowski

Bonnie E. Orlowski

Senior Vice President & Head of Consultant Relations & Financial Intermediaries at Ariel Investments LLC

Overview
RelSci Relationships

718

Relationships
RelSci Relationships are individuals Bonnie E. Orlowski likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Director, Finance, Emerging Markets at Pfizer, Inc.

Relationship likelihood: Strong

Founder at Ariel Investments LLC

Relationship likelihood: Strong

Co-Chief Executive Officer, President & Director at Ariel Investments LLC

Relationship likelihood: Strong

Vice Chairman, Head of Investment Group at Ariel Investments LLC

Relationship likelihood: Strong

Lead Director at Ariel Investments LLC

Relationship likelihood: Strong

Chief Financial Officer & Senior Executive Vice President at AXA Financial, Inc.

Relationship likelihood: Strong

Executive Vice President & Director of Research at Ariel Investments LLC

Relationship likelihood: Strong

Chief Investment Officer, International Value Equities at AllianceBernstein LP

Relationship likelihood: Strong

Executive Vice President at Ariel Investments LLC

Relationship likelihood: Strong

Senior Associate Dean for External Relations at Harvard University - Harvard Business School

Relationship likelihood: Strong

Paths to Bonnie E. Orlowski
Potential Connections via
Relationship Science
You
Bonnie E. Orlowski
Senior Vice President & Head of Consultant Relations & Financial Intermediaries at Ariel Investments LLC
Family Members
Spouse
Senior Director, Finance, Emerging Markets at Pfizer, Inc.

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Career History
Senior Vice President & Head of Consultant Relations & Financial Intermediaries
Current

Ariel utilizes a bottom-up, fundamental analysis to select quality company stocks. The firm has three investment strategy approaches offered: traditional value, deep value and global. They use different research processes for each strategies. For traditional value, they monitor a proprietary watch list which is comprised of current, former and potential new investments. The research process of deep value begins with the screening of companies on size, valuation and industry parameters. Lastly, for global strategies, they first seek to reduce the risk of large investment losses by quantitatively and qualitatively identifying and eliminating businesses that have the highest propensity to fail, based on their judgment. The firm's investment decisions will primarily be derived from bottom-up fundamental research and stock picking and are made by the portfolio manager.

Managing Director-Consultant Relations
Current

AB's investment analysts create proprietary research to support our portfolio managers, who also can conduct their own research. Their portfolio management professionals then implement our discretionary investment strategies. The firm's professionals employ a range of investment strategies to implement the advice they give to clients including: long-term purchases, short-term purchases, trading, short sales, margin transactions, option strategies including writing covered options, uncovered options and spread strategies, and taking advantage of price differentials between two or more securities (arbitrage). Quantitative analytics are utilized in some of AB's investment activities, to assist in the selection of securities or the management of investment risk. It is often necessary for them to acquire or dispose of the same securities for more than one client account at the same time. In conducting security analysis, they utilize a broad spectrum of information, including without limitation financial publications, third-party research materials, annual reports, prospectuses, regulatory filings, company press releases, corporate rating services, inspections of corporate activities and meetings with management of various companies.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$15K - $25K
2017

National Corporate Theatre Fund (NCTF) is a not-for-profit association dedicated to sustaining America's finest not-for-profit theatres, on the stage and in the community through innovative partnerships with companies, individuals and artists. From its base in New York, NCTF provides a national vehicle for the flow of theatre, collaboration and ideas to and from key national markets.

$50K - $100K
2015

National Corporate Theatre Fund (NCTF) is a not-for-profit association dedicated to sustaining America's finest not-for-profit theatres, on the stage and in the community through innovative partnerships with companies, individuals and artists. From its base in New York, NCTF provides a national vehicle for the flow of theatre, collaboration and ideas to and from key national markets.

Other Affiliations

Bonnie E. Orlowski is affiliated with Ariel Investments LLC, AllianceBernstein LP

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Bonnie E. Orlowski. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Bonnie E. Orlowski's profile does not indicate a business or promotional relationship of any kind between RelSci and Bonnie E. Orlowski.